Related references
Note: Only part of the references are listed.Rapid product analysis and increased sensitivity for quantitative determinations of botulinum neurotoxin proteolytic activity
Benjamin Rowe et al.
ANALYTICAL BIOCHEMISTRY (2010)
Light Chain Separated from the Rest of the Type A Botulinum Neurotoxin Molecule Is the Most Catalytically Active Form
Nizamettin Gul et al.
PLOS ONE (2010)
Lipid and cationic polymer based transduction of botulinum holotoxin, or toxin protease alone, extends the target cell range and improves the efficiency of intoxication
Chueh-Ling Kuo et al.
TOXICON (2010)
Identification and Biochemical Characterization of Small-Molecule Inhibitors of Clostridium botulinum Neurotoxin Serotype A
Virginia Roxas-Duncan et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Pharmacophore-guided lead optimization: The rational design of a non-zinc coordinating, sub-micromolar inhibitor of the botulinum neurotoxin serotype a metalloprotease
J. C. Burnett et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Extreme Sensitivity of Botulinum Neurotoxin Domains Towards Mild Agitation
Stephen I. Toth et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2009)
Potent New Small-Molecule Inhibitor of Botulinum Neurotoxin Serotype A Endopeptidase Developed by Synthesis-Based Computer-Aided Molecular Design
Yuan-Ping Pang et al.
PLOS ONE (2009)
Tandem fluorescent proteins as enhanced FRET-based substrates for botulinum neurotoxin activity
Melissa Pires-Alves et al.
TOXICON (2009)
Investigations into small molecule non-peptidic inhibitors of the botulinum neurotoxins
Katerina Capkova et al.
TOXICON (2009)
Methodological and cellular aspects that govern the internalization mechanisms of arginine-rich cell-penetrating peptides
Ikuhiko Nakase et al.
ADVANCED DRUG DELIVERY REVIEWS (2008)
Catalytic features of the botulinum neurotoxin a light chain revealed by high resolution structure of an inhibitory peptide complex
Nicholas R. Silvaggi et al.
BIOCHEMISTRY (2008)
SNAP-25 substrate peptide (residues 180-183) binds to but bypasses cleavage by catalytically active Clostridium botulinum neurotoxin E
Rakhi Agarwal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Structure- and substrate-based inhibitor design for Clostridium botulinum neurotoxin serotype A
Desigan Kumaran et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
A Potent Peptidomimetic Inhibitor of Botulinum Neurotoxin Serotype A Has a Very Different Conformation than SNAP-25 Substrate
Jorge E. Zuniga et al.
STRUCTURE (2008)
Substrate binding mode and its implication on drug design for botulinum neurotoxin A
Desigan Kumaran et al.
PLOS PATHOGENS (2008)
Synthesis and structure-activity relationships of second-generation hydroxamate botulinum neurotoxin A protease inhibitors
Katerina Capkova et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Computer-Aided Lead Optimization: Improved Small-Molecule Inhibitor of the Zinc Endopeptidase of Botulinum Neurotoxin Serotype A
Jing Tang et al.
PLOS ONE (2007)
A refined pharmacophore identifies potent 4-amino-7-chloroquinoline-based inhibitors of the botulinum neurotoxin serotype a metalloprotease
James C. Burnett et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Structures of Clostridium botulinum neurotoxin serotype a light chain complexed with small-molecule inhibitors highlight active-site flexibility
Nicholas R. Silvaggi et al.
CHEMISTRY & BIOLOGY (2007)
The role of released ATP in killing Candida albicans and other extracellular microbial pathogens by cationic peptides
Slavena Vylkova et al.
PURINERGIC SIGNALLING (2007)
An in vitro and in vivo disconnect uncovered through high-throughput identification of botulinum neurotoxin A antagonists
Lisa M. Eubanks et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Inhibition of metalloprotease botulinum serotype A from a pseudo-peptide binding mode to a small molecule that is active in primary neurons
James C. Burnett et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Synthesis, characterization and development of a high-throughput methodology for the discovery of botulinum neurotoxin A inhibitors
Grant E. Boldt et al.
JOURNAL OF COMBINATORIAL CHEMISTRY (2006)
Identification of a potent botulinum neurotoxin a protease inhibitor using in situ lead identification chemistry
GE Boldt et al.
ORGANIC LETTERS (2006)
Expression, purification, and characterization of Clostridium botulinum type B light chain
J Gilsdorf et al.
PROTEIN EXPRESSION AND PURIFICATION (2006)
Identification of the amino acid residues rendering TI-VAMP insensitive toward botulinum neurotoxin B
S Sikorra et al.
JOURNAL OF MOLECULAR BIOLOGY (2006)
Identification of a botulinum neurotoxin A protease inhibitor displaying efficacy in a cellular model
Grant E. Boldt et al.
CHEMICAL COMMUNICATIONS (2006)
Inhibitory effect of green tea extract on β-amyloid-induced PC12 cell death by inhibition of the activation of NF-κB and ERK/p38 MAP kinase pathway through antioxidant mechanisms
SY Lee et al.
MOLECULAR BRAIN RESEARCH (2005)
Botulinum neurotoxin serotype F: Identification of substrate recognition requirements and development of inhibitors with low nanomolar affinity
JJ Schmidt et al.
BIOCHEMISTRY (2005)
Oral delivery of peptide drugs - Barriers and developments
JH Hamman et al.
BIODRUGS (2005)
Activation and signaling of the p38 MAP kinase pathway
T Zarubin et al.
CELL RESEARCH (2005)
Pathway to the clinic: Inhibition of p38 MAP kinase. A review of ten chemotypes selected for development
DM Goldstein et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2005)
Substrate recognition strategy for botulinum neurotoxin serotype A
MA Breidenbach et al.
NATURE (2004)
Autocatalytically fragmented light chain of botulinum A neurotoxin is enzymatically active
SA Ahmed et al.
BIOCHEMISTRY (2003)
Novel small molecule inhibitors of botulinum neurotoxin A metalloprotease activity
JC Burnett et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Expression, purification, and efficacy of the type A botulinum neurotoxin catalytic domain fused to two translocation domain variants
MJ Jensen et al.
TOXICON (2003)
A high-affinity competitive inhibitor of type A botulinum neurotoxin protease activity
JJ Schmidt et al.
FEBS LETTERS (2002)
STAT4 serine phosphorylation is critical for IL-12-induced IFN-γ production but not for cell proliferation
A Morinobu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Regulation of HLA-DR and co-stimulatory molecule expression on natural killer T cells by granulocyte-macrophage colony-stimulating factor
KU Saikh et al.
IMMUNOLOGY (2002)
Possible existence of common internalization mechanisms among arginine-rich peptides
T Suzuki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Light chain of botulinum a neurotoxin expressed as an inclusion body from a synthetic gene is catalytically and functionally active
SA Ahmed et al.
JOURNAL OF PROTEIN CHEMISTRY (2000)